checkAd

     706  0 Kommentare Prominex Provides Further Update on Its Activities in Medical Marijuana and Hemp Industries - Seite 4

    TSX Venture Exchange Approval Required and Possible Restrictions on Business of the Issuer

    The Company or any company that it may invest in or acquire would require the conditional approval of the TSX Venture Exchange prior to the finalization of the acquisition and or agreement. In addition, as part of its conditional approval, the Exchange may require as a condition to listing that the Company (the "Issuer") deliver an undertaking confirming that, while listed on the Exchange, the Issuer will only conduct the business of production, acquisition, sale and distribution of medical marijuana or hemp in Canada as permitted under the Health Canada License. 

    Any undertaking could have an adverse effect on the Issuer's ability to expand its business into other areas including the provision of non-medical marijuana in the event that the laws were to change to permit such sales. Any undertaking may prevent the Issuer from expanding into new areas of business when the Issuer's competitors have no such restrictions. All such restrictions could materially and adversely affect the growth, business, financial condition, and results of operations of the Issuer. There is no guarantee that the TSX Venture exchange would approve any transaction of the Company to invest in or acquire a project the in the medical marijuana and or hemp industries.

    Other Risk Factors

    Other risk factors that should be carefully considered in evaluating the Company or any Company that it may invest in or acquire are; the Reliance on a Single Facility, Reliance on Management, Factors which may Prevent Realization of Growth Targets, Competition, Risks Inherent in an Agricultural Business, Vulnerability to Rising Energy Costs, Transportation Disruptions, Unfavourable Publicity or Consumer Perception, Product Liability, Product Recalls, Reliance on Key Inputs, Dependence on Suppliers and Skilled Labour, Difficulty of Forecast, Operating Risk and Insurance Coverage, Conflicts of Interest, Litigation, and Environmental and Employee Health and Safety Regulations. 

    There can be no assurance that any one of these risk factors would not impact the Company's ability to fund capital expenditures or acquisitions associated with the medical marijuana and hemp industries and would limit and may have a material adverse effect start-up and planned operations. 

    About Prominex

    Lesen Sie auch

    Prominex is a TSX-Venture listed exploration and development company trading under the symbol "PXR." During the past several years, Prominex has been exploring primarily for zinc-lead-copper-silver-gold mineral deposits. Currently, Prominex is evaluating two projects within a base metal rich area of central Newfoundland, home to formerly producing world-class base metal deposits at Buchans and the currently producing Duck Pond zinc-copper mine owned and operated by Teck. The Company's two major assets are the historic Tulks Hill and the Reid Lot 50 projects, both situated in central Newfoundland. 

    ON BEHALF OF THE BOARD
    "Gordon Barron"
    President and CEO

    Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release, and no securities regulatory authority has approved or disapproved of the contents of this release.

    FOR FURTHER INFORMATION, PLEASE CONTACT:
    Gordon Barron
    President and CEO
    Prominex Resource Corp.
    1.604.566.1094
    www.prominex.ca

    Seite 4 von 4



    Verfasst von Marketwired
    Prominex Provides Further Update on Its Activities in Medical Marijuana and Hemp Industries - Seite 4 VANCOUVER, BC--(Marketwired - November 19, 2014) - Prominex Resource Corp. (the "Company" or "Prominex") (TSX VENTURE: PXR) announced that it is re-issuing its news release of November 18th, 2014 to provided further disclosure regarding the Risks …